Massachusetts Financial Services’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $696K | Sell |
100,753
-2,693
| -3% | -$20.8K | ﹤0.01% | 870 |
|
|
2025
Q4 | $912K | Sell |
103,446
-35,359
| -25% | -$195K | ﹤0.01% | 835 |
|
|
2025
Q3 | $693K | Sell |
138,805
-38,245
| -22% | -$177K | ﹤0.01% | 814 |
|
|
2025
Q2 | $836K | Buy |
177,050
+2,191
| +1% | +$9.58K | ﹤0.01% | 831 |
|
|
2025
Q1 | $803K | Sell |
174,859
-3,988
| -2% | -$18.6K | ﹤0.01% | 817 |
|
|
2024
Q4 | $857K | Sell |
178,847
-5,334
| -3% | -$25.6K | ﹤0.01% | 823 |
|
|
2024
Q3 | $864K | Buy |
+184,181
| New | +$987K | ﹤0.01% | 803 |
|
|
2024
Q2 | – | Sell |
-136,340
| Closed | -$560K | – | 897 |
|
|
2024
Q1 | $560K | Sell |
136,340
-303
| -0.2% | -$1.21K | ﹤0.01% | 809 |
|
|
2023
Q4 | $577K | Sell |
136,643
-4,316
| -3% | -$17.4K | ﹤0.01% | 797 |
|
|
2023
Q3 | $609K | Sell |
140,959
-5,401
| -4% | -$30K | ﹤0.01% | 795 |
|
|
2023
Q2 | $965K | Sell |
146,360
-3,449
| -2% | -$22.1K | ﹤0.01% | 754 |
|
|
2023
Q1 | $1.02M | Sell |
149,809
-4,234
| -3% | -$29.8K | ﹤0.01% | 758 |
|
|
2022
Q4 | $1.14M | Buy |
154,043
+3,261
| +2% | +$31.8K | ﹤0.01% | 766 |
|
|
2022
Q3 | $1.49M | Sell |
150,782
-1,375
| -0.9% | -$14.5K | ﹤0.01% | 756 |
|
|
2022
Q2 | $1.66M | Buy |
152,157
+768
| +0.5% | +$7.96K | ﹤0.01% | 743 |
|
|
2022
Q1 | $1.71M | Buy |
151,389
+1,554
| +1% | +$20.4K | ﹤0.01% | 765 |
|
|
2021
Q4 | $2.35M | Sell |
149,835
-3,035
| -2% | -$52.9K | ﹤0.01% | 764 |
|
|
2021
Q3 | $2.62M | Sell |
152,870
-2,006
| -1% | -$35.1K | ﹤0.01% | 754 |
|
|
2021
Q2 | $3.33M | Buy |
154,876
+71,101
| +85% | +$1.27M | ﹤0.01% | 736 |
|
|
2021
Q1 | $1.26M | Sell |
83,775
-14,389
| -15% | -$233K | ﹤0.01% | 821 |
|
|
2020
Q4 | $1.29M | Sell |
98,164
-987
| -1% | -$11.9K | ﹤0.01% | 779 |
|
|
2020
Q3 | $958K | Buy |
+99,151
| New | +$1.06M | ﹤0.01% | 778 |
|
|
2019
Q1 | – | Sell |
-58,810
| Closed | -$1.54M | – | 872 |
|
|
2018
Q4 | $1.54M | Buy |
58,810
+4,587
| +8% | +$108K | ﹤0.01% | 732 |
|
|
2018
Q3 | $1.25M | Buy |
+54,223
| New | +$1.11M | ﹤0.01% | 770 |
|
|
2018
Q2 | – | Sell |
-12,957
| Closed | -$218K | – | 867 |
|
|
2018
Q1 | $218K | Buy |
12,957
+200
| +2% | +$3.35K | ﹤0.01% | 830 |
|
|
2017
Q4 | $194K | Buy |
12,757
+1,790
| +16% | +$26.6K | ﹤0.01% | 839 |
|
|
2017
Q3 | $196K | Buy |
+10,967
| New | +$184K | ﹤0.01% | 835 |
|
|
2017
Q2 | – | Sell |
-45,562
| Closed | -$638K | – | 890 |
|
|
2017
Q1 | $638K | Buy |
45,562
+541
| +1% | +$7.71K | ﹤0.01% | 793 |
|
|
2016
Q4 | $718K | Buy |
+45,021
| New | +$724K | ﹤0.01% | 798 |
|
Other funds holding VNDA
ACM
VCM
